BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5262254)

  • 1. Effect of triamcinolone administered every other day on pituitary and adrenal function.
    Del Toro RA; Román LA
    Bol Asoc Med P R; 1968 May; 60(5):238-45. PubMed ID: 5262254
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of the hypothalamus-pituitary-adrenal system by intra-articular triamcinolone diacetate.
    Wellington JE; van Kan BL; Jaitly KD
    J Endocrinol; 1970 Dec; 48(4):lxxx+. PubMed ID: 5489047
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of long-acting parenteral corticosteroids on adrenal function.
    Mikhail GR; Livingood CS; Mellinger RC; Paige TN; Salyer HL
    Arch Dermatol; 1969 Sep; 100(3):263-8. PubMed ID: 4241801
    [No Abstract]   [Full Text] [Related]  

  • 4. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function.
    Mikhail GR; Sweet LC; Mellinger RC
    Ann Allergy; 1973 Jul; 31(7):337-43. PubMed ID: 4352151
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complications of corticosteeroid therapy in children].
    Matveev MP; Gamburg RL; Solomatina OG; Ignatova MS; Gavriushova LP
    Vopr Okhr Materin Det; 1971 May; 16(5):3-9. PubMed ID: 5142473
    [No Abstract]   [Full Text] [Related]  

  • 6. [Limited usefulness of corticosteroid therapy (author's transl)].
    Fujimori I
    Ryumachi; 1981 Mar; 21(1):80-6. PubMed ID: 7025253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local effects of triamcinolone hexacetonide administered intra-articularly].
    Astorga G; Rossi G; Campodonico M; Muñoz A
    Rev Med Chil; 1970; 98(9):610-5. PubMed ID: 5509798
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of high doses of glucocorticoids in patients with rheumatic diseases].
    Dormidontov EN; Korshunov NI; Baranova EIa; Zheltkevich SN; Razumova EB
    Ter Arkh; 1985; 57(8):12-6. PubMed ID: 4071425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of respiratory function in patients with rheumatoid arthritis and systemic lupus erythematosus during complex therapy].
    Siniachenko VV; Gol'tsman RR; Siniachenko OV
    Vopr Revm; 1976; (1):44-8. PubMed ID: 982933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin stimulus therapy in collagen diseases].
    Ippolito A; Giacovazzo M; Montervino C; Spagna G; Giovannini C
    Reumatismo; 1968; 20(5):561-4. PubMed ID: 4310366
    [No Abstract]   [Full Text] [Related]  

  • 11. [The inhibitory effect of anti-inflammatory equipotent doses of dexamethasone and triamcinolone on the secretion rhythm of adrenal cortex steroids].
    Radvila A; Dettwiler W; Rohner R; Studer H
    Schweiz Med Wochenschr; 1969 May; 99(19):709-11. PubMed ID: 5785439
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adrenocortical function during discontinuous administration of triamcinolone].
    De Spada EF; Dahl V; Bergadá C
    Medicina (B Aires); 1978; 38(5):502-6. PubMed ID: 368499
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of chloroquine phosphate on the glucocorticoid function of the adrenal cortex in patients with lupus erythematosus].
    Berezhnaia LA
    Vestn Dermatol Venerol; 1967 Jan; 41(1):27-8. PubMed ID: 5616446
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal function in patients treated with long-term depot tetracosactrin.
    Irvine WJ; Cullen DR; Khan SA; Ratcliffe JG
    Br Med J; 1971 Mar; 1(5750):630-6. PubMed ID: 4323439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term immunosuppressive treatment of progressive chronic polyarthritis and lupus erythematosus].
    Klein G; Möstl S
    Z Rheumaforsch; 1970; 29(3):67-74. PubMed ID: 5506505
    [No Abstract]   [Full Text] [Related]  

  • 16. Single daily dose corticosteroid treatment. Effect on adrenal function and therapeutic efficacy in various diseases.
    Myles AB; Bacon PA; Daly JR
    Ann Rheum Dis; 1971 Mar; 30(2):149-53. PubMed ID: 4328107
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adrenal circadian rhythm and delayed-action corticoids].
    D'Agata R; Mughini L; Distefano C; Ferlito S
    Rass Neurol Veg; 1969; 23(5):219-29. PubMed ID: 4328313
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of new 9,11-dihalogenated corticosteroids in various types of alopecia. II. Pituitary-adrenal responsiveness in patients treated with 16 alpha-methyl-dichlorisone alcohol.
    Griboff SI; Futterweit W
    J Mt Sinai Hosp N Y; 1967; 34(2):130-4. PubMed ID: 5232041
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic activity and effects on adrenal function, of the administration of 6-alpha-fluoro-16-alpha-methyl-prednisolone-21-acetate in single doses every 48 hours in patients with rheumatoid arthritis].
    Toccafondi R
    Clin Ter; 1967 Aug; 42(4):315-40. PubMed ID: 5608822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.